Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Anxiety Disorders
NCT03549819Phase 3Unknown
- Sponsor
- McMaster University
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), panic disorder, agoraphobia, sponsored by McMaster University. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)panic disorderagoraphobia
Beyond the preview
Go deeper on NCT03549819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549819.